Stockscreener 앱 받기
1.47
1.38%
0.02
시간 외 거래:
1.42
-0.05
-3.40%
전일 마감가:
$1.45
열려 있는:
$1.4
하루 거래량:
87,256
Relative Volume:
0.07
시가총액:
$4.83M
수익:
$1.31M
순이익/손실:
$-7.47M
주가수익비율:
-0.2038
EPS:
-7.2117
순현금흐름:
$-5.11M
1주 성능:
+8.89%
1개월 성능:
-15.52%
6개월 성능:
-77.73%
1년 성능:
+37.38%
1일 변동 폭
$1.40
$1.48
1주일 범위
$1.30
$1.52
52주 변동 폭
$0.226
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
SPRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
1.47 | 4.77M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scisparc Ltd 주식(SPRC)의 최신 뉴스
What drives SciSparc Ltd stock priceHigh Dividend Yield Stocks & Small Budget Capital Growth - earlytimes.in
Libord Securities Limited Testing Reversal Zone on Weekly ChartMarket Sentiment Report & Outstanding Investment Returns - earlytimes.in
What analysts say about SciSparc Ltd stockStock Correlation Metrics & Daily Tips From Top Market Analysts - earlytimes.in
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SciSparc says Neurothera Labs granted patent by Israeli Patent Office - MSN
SciSparc Calls February 2026 Meeting to Approve New Deloitte Auditor and Executive Equity Awards - TipRanks
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech By Investing.com - Investing.com Nigeria
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech - Investing.com India
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects - The Manila Times
SciSparc Ltd.'s Majority-Owned NeuroThera Labs Receives Patent for Opioid-N-acylethanolamine Combination to Enhance Pain Management - Quiver Quantitative
New opioid drug combo is patented for strong pain relief with fewer side effects - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Catalysts: How SciSparc Ltd stock benefits from global expansionDividend Hike & High Accuracy Buy Signal Tips - moha.gov.vn
Aug Drivers: Is SciSparc Ltd stock oversold or undervaluedMarket Risk Summary & High Conviction Buy Zone Picks - moha.gov.vn
Market Wrap: Is SciSparc Ltd. stock oversold or undervaluedWeekly Gains Report & Verified Momentum Stock Ideas - moha.gov.vn
How strong is SciSparc Ltd. stock revenue growthJuly 2025 PostEarnings & Weekly Breakout Watchlists - Улправда
SciSparc (SPRC) Stock Price, Quote, News & History - Benzinga
Can SciSparc Ltd. stock deliver strong Q4 earningsMarket Sentiment Review & Daily Risk Controlled Trade Plans - Улправда
Is SciSparc Ltd. stock a smart buy before Fed meetingJuly 2025 PostEarnings & Low Risk Entry Point Guides - DonanımHaber
Why SciSparc Ltd. stock remains on watchlistsQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - DonanımHaber
Why analysts remain bullish on SciSparc Ltd. stockAnalyst Downgrade & Weekly Return Optimization Plans - DonanımHaber
SciSparc Ltd. Announces $2.2 Million Securities Offering - MSN
SciSparc gets Nasdaq extension to regain compliance - MSN
Scisparc Ltd (SPRC) - MSN
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - MSN
SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com
SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast - ts2.tech
Will SciSparc Ltd. stock outperform growth indexesJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser
NeuroThera to acquire 55% stake in quantum computing bio data company - MSN
SciSparc Shares Slide After Revealing Plans to Acquire MUSE Endoscopic System IP - MSN
SciSparc’s NeuroThera Labs Eyes Quantum Leap with New Acquisition - TipRanks
SciSparc Ltd. Announces NeuroThera Labs' Planned Acquisition of Quantum Computing Bio Data Company - Quiver Quantitative
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company - The Manila Times
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to - GlobeNewswire
SciSparc plans to enter GERD device market with IP portfolio acquisition - MSN
NeuroThera to acquire 55% stake in quantum computing bio data firm - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
SciSparc (SPRC) Stock Analysis Report | Financials & Insights - Benzinga
SciSparc stock tumbles after announcing MUSE system acquisition plans By Investing.com - Investing.com UK
SciSparc Ltd. (SPRC) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
SciSparc stock tumbles after announcing MUSE system acquisition plans - Investing.com
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com Nigeria
SciSparc to acquire MUSE endoscopic system patents from Xylo - Investing.com
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio - The Manila Times
Scisparc plans on entering the multi-billion-dollar GERD device market with acquisition of an approved IP portfolio - marketscreener.com
Scisparc Ltd (SPRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):